SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001701541-21-000025
Filing Date
2021-05-07
Accepted
2021-05-07 07:19:53
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bdtx-20210331.htm   iXBRL 10-Q 911097
2 EX-31.1 exhibit311_q12021.htm EX-31.1 12139
3 EX-31.2 exhibit312_q12021.htm EX-31.2 11973
4 EX-32.1 exhibit321_q12021.htm EX-32.1 9418
  Complete submission text file 0001701541-21-000025.txt   4562571

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdtx-20210331.xsd EX-101.SCH 28099
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bdtx-20210331_cal.xml EX-101.CAL 64837
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bdtx-20210331_def.xml EX-101.DEF 124671
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdtx-20210331_lab.xml EX-101.LAB 426278
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdtx-20210331_pre.xml EX-101.PRE 273006
10 EXTRACTED XBRL INSTANCE DOCUMENT bdtx-20210331_htm.xml XML 721156
Mailing Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39200 | Film No.: 21900236
SIC: 2836 Biological Products, (No Diagnostic Substances)